Aptus Endosystems

Medical Devices & EquipmentSeries BSunnyvale, USaptusendosystems.com

Latest round

Series B

Last raised

Jun 2012

Total raised

$82M

Investors

8

About Aptus Endosystems

, is based in Sunnyvale, US and medical technology company and developed advanced technology for the endovascular treatment of aortic aneurysm disease.

Who invested in Aptus Endosystems

8 investors across 4 rounds

See all investors in Aptus Endosystems

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 27, 2012

    Amount

    $25M

    Investors

    Locked

  2. Series E

    Aug 30, 2010

    Amount

    $15M

    Investors

    Locked

  3. Series D

    Jan 7, 2009

    Amount

    $22M

    Investors

    Locked

  4. Series B

    Mar 28, 2006

    Amount

    $20M

    Investors

    Locked

Questions about Aptus Endosystems

Who invested in Aptus Endosystems?

Aptus Endosystems has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Aptus Endosystems raised?

Aptus Endosystems has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Aptus Endosystems last raise money?

Aptus Endosystems's most recent round on record is a Series B, in Jun 2012.

What does Aptus Endosystems do?

, is based in Sunnyvale, US and medical technology company and developed advanced technology for the endovascular treatment of aortic aneurysm disease.

Where is Aptus Endosystems headquartered?

Aptus Endosystems is headquartered in Sunnyvale, US.

Which VCs invest in companies like Aptus Endosystems?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Aptus Endosystems's stage. Their profiles are linked below.

Raising like Aptus Endosystems? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.